{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:54:45Z","timestamp":1789397685926,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.hrthm.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:24:57Z","timestamp":1587965097000},"page":"860-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"PB","title":["Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Linda","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-715X","authenticated-orcid":false,"given":"Neeraj","family":"Javadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole M.","family":"Rogovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi T.","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Broberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa G.","family":"Tereshchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.01.016_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.01.016_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/europace\/euz190","article-title":"The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis","volume":"21","author":"Willy","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.01.016_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacep.2016.02.008","article-title":"Outcomes in patients with congenital heart disease receiving the subcutaneous implantable-cardioverter defibrillator: results from a pooled analysis from the IDE Study and the EFFORTLESS S-ICD Registry","volume":"2","author":"D'Souza","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pace.13537","article-title":"Eligibility for subcutaneous implantable cardioverter defibrillators in the adult congenital heart disease population","volume":"42","author":"Garside","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib5","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib6","series-title":"Pulse Generator User's Manual: Emblem\u2122 S-ICD: Subcutaneous Implantable Cardioverter Defibrillator Model A209","year":"2015"},{"key":"10.1016\/j.hrthm.2020.01.016_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jce.13326","article-title":"Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral","volume":"28","author":"Bernier","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1540-8159.2012.03497.x","article-title":"Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis","volume":"35","author":"Yuhas","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.compbiomed.2018.05.002","article-title":"The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator","volume":"102","author":"Thomas","year":"2018","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.hrthm.2020.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12461","article-title":"Conventional and right-sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death","volume":"22","author":"Alonso","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib12","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.01.016_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.115.019307","article-title":"Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010","volume":"134","author":"Gilboa","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.01.016_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2017.05.132","article-title":"Mortality in adults with congenital heart disease","volume":"245","author":"Naidu","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib15","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","article-title":"Sudden cardiac death in adult congenital heart disease","volume":"126","author":"Koyak","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.01.016_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11936-019-0749-9","article-title":"Diagnostic and therapeutic approach to arrhythmias in adult congenital heart disease","volume":"21","author":"Guerrier","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2020.01.016_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2015.09.083","article-title":"Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease","volume":"203","author":"Bordachar","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/pace.13017","article-title":"The role of conventional and right-sided ECG screening for subcutaneous ICD in a tetralogy of Fallot population","volume":"40","author":"Alonso","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1253\/circj.CJ-16-0153","article-title":"right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease","volume":"80","author":"Okamura","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2020.01.016_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euu375","article-title":"Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping","volume":"17","author":"Zeb","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.01.016_bib21","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.hlc.2015.07.015","article-title":"Right parasternal electrode configuration converts a failed electrocardiographic screening to a pass for subcutaneous implantable cardioverter-defibrillator implantation","volume":"24","author":"Chan","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrthm.2020.01.016_bib22","first-page":"yty099","article-title":"Implantation of a subcutaneous implantable cardioverter defibrillator with right parasternal electrode position in a patient with D-transposition of the great arteries and concomitant AAI pacemaker: a case report","volume":"2","author":"Luker","year":"2018","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.hrthm.2020.01.016_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/joa3.12145","article-title":"Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold","volume":"35","author":"Wakabayashi","year":"2019","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hrthm.2020.01.016_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1253\/circj.CJ-15-0883","article-title":"Efficacy and myocardial injury with subcutaneous implantable cardioverter defibrillators\u2014computer simulation of defibrillation shock conduction","volume":"80","author":"Noro","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2020.01.016_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00392-017-1194-y","article-title":"Right versus left parasternal electrode position in the entirely subcutaneous ICD","volume":"107","author":"Bettin","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2016.02.085","article-title":"Sex-specific data for the subcutaneous implantable cardioverter-defibrillator","volume":"68","author":"Dhruva","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.01.016_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/pace.12802","article-title":"Left and right parasternal sensing for the S-ICD in adult congenital heart disease patients and normal controls","volume":"39","author":"Wilson","year":"2016","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:50:11Z","timestamp":1761547811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1547527120300291"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.016","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19009175","asserted-by":"object"}]},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}